Mapping of antigenic determinants of purified, lipid-free human serum amyloid A proteins

Scandinavian Journal of Immunology

Volumn 48, Issue 5, 1998, Pages 557-561

  Malle, E ^a   Herz, R ^a   Artl, A ^a   Ibovnik, A ^a   Andreae, F ^b   Sattler, W ^a  

^a UNIVERSITY OF GRAZ   (Austria)

^b piCHEM Research and Development   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; AMINO ACID; AMYLOID A PROTEIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; EPITOPE; HIGH DENSITY LIPOPROTEIN; LYMPHOKINE;

ACUTE PHASE RESPONSE; AMINO TERMINAL SEQUENCE; AMYLOIDOSIS; ANTIBODY AFFINITY; ANTIBODY COMBINING SITE; ANTIGEN RECOGNITION; ANTIGENIC VARIATION; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL TRANSPORT; DIAGNOSTIC VALUE; EPITOPE MAPPING; HUMAN; HUMAN TISSUE; HYDROPHOBICITY; INFLAMMATION; LIVER CELL; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN FOLDING; SEQUENCE HOMOLOGY; TRANSLATION REGULATION;

EPITOPE MAPPING; EPITOPES, B-LYMPHOCYTE; HUMANS; LIPIDS; SERUM AMYLOID A PROTEIN;

EID: 0031763657     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1998.00439.x     Document Type: Article

References (17)

1. Malle E, Steinmetz A, Raynes JG. Serum amyloid A (SAA): an acute phase protein and apolipoprotein. Atherosclerosis 1993;102: 131-46.
2. Uhlar CM, Burgess CJ, Sharp PM, Whitehead AS. Evolution of the serum amyloid A (SAA) protein superfamily. Genomics 1994;19: 228-35.
3. Kluve-Beckerman B, Dwulet FE, Benson MD. Human serum amyloid A. Three hepatic mRNAs and the corresponding proteins in one person. J Clin Invest 1988;82:1670-5.
4. Kushner I. The acute phase response: an overview. Methods Enzymol 1988;163:373-83.
5. Malle E, De Beer FC. Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice. Eur J Clin Invest 1996;26:427-35.
6. Sipe JD. Amyloidosis. Annu Rev Biochem 1992;61:947-75.
7. Husebekk A, Skogen B, Husby G, Marhaug G. Transformation of amyloid precursor SAA to protein AA and incorporation in amyloid fibrils in vivo. Scand J Immunol 1985;21:283-7.
8. Kisilevsky R, Lindhorst E, Anesin JB, Young D, Bagshaw W. Acute phase serum amyloid A (SAA) and cholesterol transport during acute inflammation: a hypothesis. Amyloid: Int J Exp Clin Invest 1996;3: 252-60.
9. Clifton PM, Malcolm Mackinnon A, Barter PJ. Effects of serum amyloid A protein (SAA) on composition, size, and density of high density lipoprotein in subjects with myocardial infarction. J Lipid Res 1985;26:1389-98.
10. Kisilevsky R, Subrahmanyan L. Serum amyloid A changes high density lipoprotein's cellular affinity. A clue to serum amyloid A's principal function. Lab Invest 1992;66:778-85.
11. Gerrity RG. The role of the monocyte in atherogenesis. I. Transition of blood-borne monocytes into foam cells in fatty streaks. Am J Pathol 1981;103:181-90.
12. 3+ as a specific probe for time-resolved fluorometric immunoassay. J Immunol Methods 1995;182:131-44.
13. Malle E, Heß H, Münscher G, Knipping G, Steinmetz A. Purification of serum amyloid A and its isoforms from human plasma by hydrophobic interaction chromatography and preparative isoelectric focusing. Electrophoresis 1992;13:422-8.
14. Malle E, Hazell L, Stocker R, Sattler W, Esterbauer H, Waeg G. Immunologic detection and measurement of hypochlorite-modified LDL with specific monoclonal antibodies. Arterioscler Thromb Vasc Biol 1995;15:982-9.
15. Bausserman LL, Herbert PN, Forte T et al. Interaction of the serum amyloid A proteins with phospholipid. J Biol Chem 1983;258: 10681-8.
16. Swaney JB, O'Brien K. Cross-linking studies of the self-association properties of apo-A-I and apo-A-II from human high density lipoprotein. J Biol Chem 1978;253:7069-77.
17. 1. Presumptive identification of calcium and lipid binding sites. Mol Biol Med 1986;3:387-407.